Processed meat consumption linked to breast cancer risk
Studies on red and processed meat consumption with breast cancer risk have generated inconsistent results. An International Journal of Cancer […]
» Read moreHome » Colon Cancer »
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not […] Vitamin D is already well known for its benefits in building healthy bones. A new study supports the idea that […] Cancer cells often have mutations in their DNA that can give scientists clues about how the cancer started or which […] New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal […] The maintenance workers of the vascular system, pericyte cells envelop the surface of blood vessels, supporting their stability, growth and […] A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not […] University of Toronto researchers have uncovered why some cancers grow faster than others. The team led by Liliana Attisano, Professor […] Colorectal cancer is the third most commonly diagnosed cancer in the United States, but with timely screenings, it is also […] A new chemical compound with the potential to destroy hard-to-treat cancer cells has been developed and tested by scientists at […]
New cancer vaccine shows early promise for patients with HER2-positive cancers
Obesity and vitamin D deficiency may indicate greater risk for breast cancer
New method of pinpointing cancer mutations could lead to more targeted treatments: Researchers develop approach to yield more complete picture of cancer
Neuropsychiatric disorders: Dopamine study offers hope for improved treatments
How nearby cells shield tumor cells from targeted therapy
Financial disclosure lacking in publication of clinical trials, study finds
New way to break cancer’s vicious cycle
Colorectal Cancer Screening: Guidelines, Options and Risks
Compound discovered that targets cancer cells lacking the protective p53 ‘guardian gene’
